World Journal of Endocrine Surgery

Register      Login

VOLUME 12 , ISSUE 1 ( January-April, 2020 ) > List of Articles

CASE REPORT

Sagliker Syndrome: A Case Report on a Rare Case of Severe Renal Osteodystrophy Due to Untreated Secondary Hyperparathyroidism

Luis B Castro, Rui Mendes, Fátima B Coelho, Vanessa Capella, Andreia B Silva

Citation Information : Castro LB, Mendes R, Coelho FB, Capella V, Silva AB. Sagliker Syndrome: A Case Report on a Rare Case of Severe Renal Osteodystrophy Due to Untreated Secondary Hyperparathyroidism. World J Endoc Surg 2020; 12 (1):38-40.

DOI: 10.5005/jp-journals-10002-1281

License: CC BY-NC 4.0

Published Online: 20-08-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: To describe a rare clinical syndrome related to secondary hyperparathyroidism (SHP). Background: Sagliker syndrome is a rare entity associated with long-term untreated SHP that results in severe renal osteodystrophy with typical skeletal deformities (mostly craniofacial), high levels of parathormone (PTH), and difficult medical control of the disease. Adequate treatment of the secondary hyperparathyroidism generally includes a surgical approach, and is essential to stop the progression of the disease. Case description: We present the case of a 26-year-old African male with chronic kidney failure on dialysis since the age of 15 and severe SHP (PTH > 5,000 pg/L). He presented with craniofacial dystrophy, benign facial bone tumors, depression, and long-bone fractures. After failure of medical treatment, he underwent total parathyroidectomy with parathyroid autotransplant with normalization of the serum parathormone. “Hungry bone syndrome” was verified postoperatively. After 2 years of follow-up, the skeletal changes were stabilized without regression of the clinical spectrum. No recurrence of secondary hyperparathyroidism was identified at 1 year of follow-up. Conclusion: Identification of this syndrome is of clinical significance, allowing the identification of a subgroup of patients with predicable failure of the medical treatment of secondary hyperparathyroidism and who benefit from surgical treatment to stop the progression of the skeletal changes. Clinical significance: The early identification of this clinical syndrome may allow for better outcomes with reduced morbidity.


PDF Share
  1. van der Plas WY, Noltes ME, van Ginhoven M, et al. Secondary and tertiary hyperparathyroidism: A narrative review. Scand J Surg 2019. 1457496919866015. DOI: 10.1177/1457496919866015. [Epub ahead of print].
  2. Sagliker Y, Balal M, Sagliker Ozkaynak P, et al. Sagliker syndrome: Uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin Nephrol 2004;24(5):449–455. DOI: 10.1016/j.semnephrol.2004. 06.021.
  3. Erkan AN, Sagliker Y, Yildiz I, et al. Audiological findings in chronic kidney disease patients with Sagliker syndrome. J Ren Nutr 2010;20(5 Suppl):S56–S58. DOI: 10.1053/j.jrn.2010.06.002.
  4. Pontes FSC, Lopes MA, de Souza LL, et al. Oral and maxillofacial manifestations of chronic kidney disease mineral and bone disorder: A multicenter retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125(1):31–43. DOI: 10.1016/j.oooo.2017.09.011.
  5. Sagliker Y, Acharya V, Ling Z, et al. International study on Sagliker syndrome and uglifying human appearance in severe and late secondary hyperparathyroidism in chronic kidney disease patients. J Ren Nutr 2008;18(1):114–117. DOI: 10.1053/j.jrn.2007.10.023.
  6. Sagliker Y, Acharya V, Golea O, et al. Is survival enough for quality of life in Sagliker syndrome-uglifying human face appearances in chronic kidney disease? J Nephrol 2008;21(Suppl 13):S134–S138.
  7. Demirhan O, Arslan A, Sagliker Y, et al. Gene mutations in chronic kidney disease patients with secondary hyperparathyroidism and Sagliker syndrome. J Ren Nutr 2015;25(2):176–186. DOI: 10.1053/j.jrn.2014.12.008.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.